Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 57.56
+5.56 (10.69%)
At close: May 21, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 26.77 billion as of May 21, 2026. Its market cap has increased by 9.03% in one year.
Market Cap
26.77B
Enterprise Value
26.29B
Revenue
894.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.56
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 26.77B, an increase of 62.86%. That is a compound annual growth rate of 11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 26.77B | 0.79% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
| Dec 10, 2021 | 16.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shijiazhuang Yiling Pharmaceutical | 27.12B |
| Hubei Jumpcan Pharmaceutical | 26.49B |
| Livzon Pharmaceutical Group | 25.54B |
| Zhejiang Huahai Pharmaceutical | 24.81B |
| Walvax Biotechnology | 22.42B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.29B |
| Kangmei Pharmaceutical | 21.71B |
| Tasly Pharmaceutical Group | 21.27B |